跳至主要内容
临床试验/CTRI/2021/11/038177
CTRI/2021/11/038177尚未招募4 期

Safety and efficacy of Atropine 0.01% and 0.05% in prevention of the progression of Myopia in Indian children

Dr Siddharam S Janti0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 )Age of 5 to 16 years
  • 2 ) Myopia â?? 1D to -6 D
  • 3 )Annual myopic progression of greater than 0.5 D

排除标准

  • â??Refractive Myopia
  • â??Astigmatism >= 1.5 D
  • â??Amblyopia
  • â??Prior intraocular surgery
  • â??Allergy to atropine eye drops
  • â??Systemic diseases associated with myopia such as Marfan syndrome, Stickler syndrome
  • â??History of cardiac or significant respiratory diseases
  • â??Lack of consent for participating in the study

研究者

发起方
Dr Siddharam S Janti

相似试验